Arsenic enhances the activation of Stat1 by interferon γ leading to synergistic expression of IRF-1

Oncogene

Volumn 22, Issue 57, 2003, Pages 9121-9130

  Chelbi alix, Mounira K ^a   Bobé, Pierre ^a   Benoit, Gerard ^b   Canova, Antony ^c   Pine, Richard ^c  

^a Laboratory of Viral Oncology   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

APL; Apoptosis; Interferon; IRF 1; Stat1

Indexed keywords

ALPHA INTERFERON; ARSENIC TRIOXIDE; CYTOKINE; GAMMA INTERFERON; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; LIPOCORTIN 5; PROMYELOCYTIC LEUKEMIA PROTEIN; STAT1 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL STRUCTURE; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MATURATION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; STAINING; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; ARSENIC; ARSENICALS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; LEUKEMIA, PROMYELOCYTIC, ACUTE; OXIDES; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; SUPEROXIDES; TRANS-ACTIVATORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0347949502     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207090     Document Type: Article

References (43)

1. Bazarbachi A, El-Sabban ME, Nasr R, Quignon F, Awaraji C, Kersual J, Dianoux L, Zermati Y, Haidar JH, Hermine O and de The H. (1999). Blood, 93, 278-283.
2. Chelbi-Alix MK and Pelicano L. (1999). Leukemia, 13, 1167-1174.
3. Chelbi-Alix MK, Pelicano L, Quignon F, Koken MHM, Venturini L, Stadler M, Pavlovic J, Degos L and de The H. (1995). Leukemia, 9, 2027-2033.
4. Chen G-Q, Shi X-G, Tang W, Xiong S-M, Zhu J, Cai X, Han Z-G, Ni J-H, Shi G-Y, Jia P-M, Liu M-M, He K-L, Niu C Ma J, Zhang P, Zhang T-D, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang Z-Y, de The H, Chen S-J and Chen Z. (1997a). Blood, 89, 3345-3353.
5. Chen Z, Wang Z-Y and Chen S-J. (1997b). Pharmacol. Ther., 76, 141-149.
6. Daniel M-T, Koken M, Romagné O, Barbey S, Bazarbachi A, Stadler M, Guillemin M-C, Degos L, Chomienne C and de Thé H. (1993). Blood, 82, 1858-1867.
7. de The H and Chelbi-Alix MK. (2001). Oncogene, 20, 7136-7139.
8. Duprez E, Benoit G, Flexor M, Lillehaug JR and Lanotte M. (2000). Leukemia, 14, 255-261.
9. Duprez E, Lillehaug JR, Naoe T and Lanotte M. (1996). Oncogene, 12, 2451-2459.
10. Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner PH, Berger R and Lanotte M. (1992). Leukemia, 6, 1281-1287.
11. Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A and Evans RM. (1994). Cell, 76, 333-343.
12. El-Sabban ME, Nasr R, Dbaibo G, Hermine O, Abboushi N, Quignon F, Ameisen JC, Bex F, de The H and Bazarbachi A. (2000). Blood, 96, 2849-2855.
13. Foss GS and Prydz H. (1999). J. Biol. Chem., 274, 35196-35202.
14. Gianni M, Koken MHM, Chelbi-Alix MK, Benoit G, Lanotte M, Chen Z and de Thé H. (1998). Blood, 91, 4300-4310.
15. Gil J and Esteban M. (2000). Apoptosis, 5, 107-114.
16. Gupta S, Yan H, Wong LH, Ralph S, Krolewski J and Schindler C. (1996). EMBO J., 15, 1075-1084.
17. Koken MHM, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E and de Thé H. (1994). EMBO J., 13, 1073-1083.
18. Kroger A, Koster M, Schroeder K, Hauser H and Mueller PP. (2002). J. Interferon Cytokine Res., 1, 5-14.
19. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F and Berger R. (1991). Blood, 77, 1080-1086.
20. Maruyama M, Fujita T and Taniguchi T. (1989). Nucleic Acids Res, 17, 3292.
21. Miller WHJ, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M and Warrell RPJ. (1995). Blood, 85, 3021-3027.
22. Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Scale JRC, Cross NCP, Goldman JM, Dmitrovsky E and Pandolfi PP. (1995). Blood, 88, 3926-3936.
23. Ohmori Y, Schreiber RD and Hamilton TA. (1997). J. Biol. Chem., 272, 14899-14907.
24. Pelicano L, Brumpt C, Pitha PM and Chelbi-Alix MK. (1999). Oncogene, 18, 3944-3953.
25. Pelicano L, Li F, Schindler C and Chelbi-Alix MK. (1997). Oncogene, 15, 2349-2359.
26. Pellegrini S and Dusanter-Fourt I. (1997). Eur. J. Biochem., 248, 615-633.
27. Percario Z, Giandomenico V, Fiorucci G, Chiantore M, Vannucchi S, Hiscott J, Affabris E and Romeo G. (1999). Cell Growth Differ., 10, 263-270.
28. Pine R. (1997). Nucleic Acids Res., 25, 4346-4354.
29. Pine R, Canova A and Schindler C. (1994). EMBO J., 13, 158-167.
30. Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, Doskeland SO and Lanotte M. (1994). Proc. Natl. Acad. Sci. USA, 91, 8428-8432.
31. Salomoni P and Pandolfi PP. (2002). Cell, 108, 165-170.
32. Schindler C and Darnell JE. Jr. (1995). Annu. Rev. Biochem., 64, 621-651.
33. Sims SH, Cha H, Romine MF, Gao P-Q, Gottlieb K and Deisseroth A. (1993). Mol Cell. Biol., 13, 690-702.
34. Stadler M, Chelbi-Alix MK, Koken MHM, Venturini L, Lee C, Saïb A, Quignon F, Pelicano L, Guillemin M-C, Schindler C and de Thé H. (1995). Oncogene, 11, 2565-2573.
35. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S and Taniguchi T. (1995). Nature, 376, 596-599.
36. Taniguchi T, Ogasawara K, Takaoka A and Tanaka N. (2001). Annu. Rev. Immunol., 19, 623-655.
37. Taniguchi T, Lamphier MS and Tanaka N. (1997). Biochim. Biophys. Acta, 1333, M9-M17.
38. Wang Z-G, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R and Pandolfi PP. (1998). Nat. Genet., 20, 266-272.
39. Warrell Jr R, de The H, Wang ZY and Degos L. (1993). N. Engl. J. Med., 329, 177-189.
40. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A and Dejean A. (1994). Cell. 76, 345-356.
41. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R and Naoe T. (1996). Cancer Res., 56, 2945-2948.
42. Zhu J, Koken MH, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z and de The H. (1997). Proc. Natl. Acad. Sci. USA, 94, 3978-3983.
43. Zhu Q, Zhang JW, Zhu HQ, Shen YL, Flexor M, Jia PM, Yu Y, Cai X, Waxman S, Lanotte M, Chen SJ, Chen Z and Tong JH. (2002). Blood, 99, 1014-1022.